IMIDAZOLOPYRIMIDIN-2-YL DERIVATIVES AS JAK INHIBITORS
New imidazopyridmin-2-yl derivatives are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use as inhibitors of Janus Kinases (JAK) for the treatment of myeloproliferative disorders, leukemia, lymphoid malignancies and solid tumors; bone marrow and organ transplant rejection; immune-mediated diseases and inflammatory diseases.
-
Page/Page column 62
(2015/07/07)
More Articles about upstream products of 887588-48-9